Biohaven's troriluzole, which initially failed a pivotal study in spinocerebellar ataxia, is now being readied for an FDA submission in this rare neurodegenerative disease. The turnabout is based ...

Dr. Melynda Barnes is responsible for Ro’s clinical strategy as well as quality and patient safety initiatives. She also shapes the company’s proprietary EMR and technology tools offered to ...

There’s a lot of open water between recognizing the potential for an app and launching one that actually makes people’s lives better. The key to getting it right is defining how the app will ...

Donald Rucker, MD is Chief Strategy Officer for 1upHealth, where he is helping to set the direction for the company’s ongoing innovations in FHIR-enabled computing and bring these to customers ...